ByHeart Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
208
- Latest Deal Type
-
Series C1
- Investors
-
14
ByHeart General Information
Description
Operator of an infant nutrition company intended to offer nutritious food for babies. The company's products are made from hand-picked ingredients using small-batch blending and sit at the forefront of immune, microbiome, cognitive, and digestive health, enabling parents to make choices so they can proactively create a strong foundation for their babies' future health.
Contact Information
Website
www.byheart.comCorporate Office
- 131 Varick Street
- 11th Floor
- New York, NY 10013
- United States
Corporate Office
- 131 Varick Street
- 11th Floor
- New York, NY 10013
- United States
ByHeart Timeline
ByHeart Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C1) | 10-Jul-2026 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 27-Mar-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 13-May-2024 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 26-Jul-2021 | $90M | $187M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 15-Apr-2020 | $96.9M | $96.9M | Completed | Generating Revenue |
ByHeart Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A3 | ||||||||
| Series A2 | 5,814,487 | $0.001000 | $1.56 | $1.56 | 1x | $1.56 | 7.94% | |
| Series A1 | 15,025,974 | $0.001000 | $4.66 | $4.66 | 1x | $4.66 | 20.52% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
ByHeart Comparisons
Industry
Financing
Details
ByHeart Competitors (6)
One of ByHeart’s 6 competitors is Bobbie (Food Products), a Venture Capital-Backed company based in Heath, OH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bobbie (Food Products) | Venture Capital-Backed | Heath, OH | ||||
| Helaina | Venture Capital-Backed | New York, NY | ||||
| Nature's One | Formerly PE-Backed | Heath, OH | ||||
| Danone | Corporation | Paris, France | ||||
| Earth's Best | Formerly VC-backed | Boulder, CO |
ByHeart Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ByHeart Patents
ByHeart Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026187968-A1 | Stabilized hydrolyzed protein emulsions for infant formula | Pending | 07-Mar-2025 | ||
| US-20260013541-A1 | Fatty acid compositions | Pending | 15-Jul-2024 | ||
| US-20260013542-A1 | Fatty acid compositions | Pending | 15-Jul-2024 | ||
| WO-2026019795-A1 | Fatty acid compositions | Pending | 15-Jul-2024 | ||
| WO-2025213137-A1 | Formulation comprising heat-treated lactoferrin for nutritional support in subjects in need thereof | Pending | 05-Apr-2024 | A23L33/19 |
ByHeart Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ByHeart Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Calm Ventures | Venture Capital | Minority | ||
| Hyperlink Ventures | Venture Capital | Minority | ||
| Sonostar Ventures | Venture Capital | Minority | ||
| AF Ventures | Growth/Expansion | Minority | ||
| Evolution VC Partners | Venture Capital | Minority |
ByHeart Investments & Acquisitions (3)
ByHeart’s most recent deal was a Corporate Asset Purchase with DairiConcepts (Allerton Facility). The deal was made on 25-Jan-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| DairiConcepts (Allerton Facility) | 25-Jan-2023 | Corporate Asset Purchase | Buildings and Property | ||
| Cascadia Nutrition | 05-Jan-2023 | Merger/Acquisition | Metal Containers and Packaging | ||
| ByHeart (Manufacturing Facility In Reading, Pennsylvania) | 01-Sep-2019 | Corporate Asset Purchase | Buildings and Property |
ByHeart Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Meridianmade Portland | Portland, OR | 2022 |
ByHeart FAQs
-
When was ByHeart founded?
ByHeart was founded in 2016.
-
Where is ByHeart headquartered?
ByHeart is headquartered in New York, NY.
-
What is the size of ByHeart?
ByHeart has 208 total employees.
-
What industry is ByHeart in?
ByHeart’s primary industry is Food Products.
-
Is ByHeart a private or public company?
ByHeart is a Private company.
-
What is ByHeart’s current revenue?
The current revenue for ByHeart is .
-
How much funding has ByHeart raised over time?
ByHeart has raised $467M.
-
Who are ByHeart’s investors?
Calm Ventures, Hyperlink Ventures, Sonostar Ventures, AF Ventures, and Evolution VC Partners are 5 of 14 investors who have invested in ByHeart.
-
Who are ByHeart’s competitors?
Bobbie (Food Products), Helaina, Nature's One, Danone, and Earth's Best are some of the 6 competitors of ByHeart.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
